For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

This new data was the result of a recent case-controlled study that aimed to assess the effects of a PDL that provides an exemption from out-of-pocket cost sharing for patients’ asthma medications on ...

Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an eosinophilic phenotype, according to a press release from GSK.Depemokimab ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Editor's note: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...

Are you one of those families racing to find new asthma medications as respiratory virus season approaches? The Massachusetts Department of Public Health is trying to help patients and families access ...

Despite a declining trend, the number of adults in the U.S. who say they did not adhere to their asthma treatment because of costs remains high, according to an observational study. From 2011-2022, ...

How does the switch to a high-deductible health plan affect children with asthma? A new study suggests that enrollment in a high-deductible health plan (HDHP) may not be associated with changes in ...

The cost of medication to treat asthma, the chronic lung disease, is stopping one in six US adults from taking their medication as it has been prescribed, researchers warned Monday. Furthermore, ...